Intellectual Property and Human Rights

Nagan, Winston P.; Munro, Robert J.; Cartner, John A.C.

doi:10.1163/9789004315525_016

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has the potential to reduce incentives for pharma companies to innovate, and for tensions between the government authorising the compulsory licences and the governments of the patentees, which can have both political and economic implications (Flynn et al, 2009;Reichman, 2009). There have been indications that the USA is not entirely at ease when states order compulsory licensing of American pharmaceuticals (Nagan et al, 2017). Compulsory licensing may be an instrument to alleviate the strictures of the patent system to some extent, but it is not the entire solution.…”

Section: The Pharmaceutical Industry and Developing Countriesmentioning

confidence: 99%

Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective

Gubby

2019

Global Policy

View full text Add to dashboard Cite

As patents grant monopolies, the patent system has a considerable impact on markets. When corporations use certain patent strategies, social welfare can be damaged. This article focuses on how corporations use patent strategies in the biomedical sector. Strategic patenting makes it possible to extend monopolies beyond the designated period and block competitors. Access to fundamental research can be restricted. Patients are disadvantaged by high monopoly prices for drugs, which can mean exclusion from treatment. It is argued here that as biomedical technologies are so vital to the welfare of people, and that in some cases are literally a matter of life or death for patients, this area of technology should not be controlled by private companies through their patent monopolies. The whole biomedical sector should be taken out of the ambit of the patent system.

show abstract

Section: The Pharmaceutical Industry and Developing Countriesmentioning

confidence: 99%

Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective

Gubby

2019

Global Policy

View full text Add to dashboard Cite

show abstract

Intellectual Property and Human Rights

Cited by 1 publication

References 0 publications

Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective

Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective

Contact Info

Product

Resources

About